Loading viewer...
earnings
Format: PDF earnings
Kopran Limited is a global pharmaceutical company operating across formulations and active pharmaceutical ingredients (APIs) verticals with state-of-the-art manufacturing facilities and presence in 50+ nations. The company serves both regulated and non-regulated markets, holding multiple accreditations from major global regulatory authorities. Kopran operates its formulations business directly and its API business through wholly-owned subsidiary Kopran Research Laboratories Ltd.
earnings
31 Pages
VimpelCom Ltd.
Deluxe Corporation Q3 2016 Earnings Call
earningsearnings
24 Pages
Deluxe Corporation
Santander UK 2021 Investor Update
earningsearnings
37 Pages
Santander UK Group Holdings plc